BIOFLOW III Asia Registry Orsiro Stent System

CompletedOBSERVATIONAL
Enrollment

387

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Coronary Artery DiseaseMyocardial IschemiaDiabetes Mellitus Type 1 or 2
Trial Locations (19)

Unknown

Queen Mary Hospital, Hong Kong

KMC Manjpal, Manial

Fortis Hospitals Bannerghatta Road, Bangalore

GKNM Hospital, Coimbatore

Divine Heart and Multi-Specialty Hospital, Lucknow

King George Medical University, Lucknow

Fortis Hospital, Mohali

Holy Family Hospital, Mumbai

BLK Super Speciality Hospital, New Delhi

Dharma Vira Heart Centre, Sir Ganga Ram Hospital, New Delhi

Fortis Escort Heart Institute, New Delhi

Ruby Hall Clinic, Pune

Institut Jantung Negara, Kuala Lumpur

Lanka Hospital, Colombo

National Hospital of Sri Lanka, Colombo

Sri Jaiewardenepura General Hospital, Colombo

Bach Mai Hospital, Hanoi

Cho Ray Hospital, Ho Chi Minh City

KA 560076

Fortis Hospitals-Bannerghatta Road, Bangalore

All Listed Sponsors
lead

BIOTRONIK Asia Pacific Pte Ltd

INDUSTRY

NCT01941290 - BIOFLOW III Asia Registry Orsiro Stent System | Biotech Hunter | Biotech Hunter